(NASDAQ: HSIC) Henry Schein's forecast annual revenue growth rate of 3.11% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.77%.
Henry Schein's revenue in 2025 is $12,669,000,000.On average, 9 Wall Street analysts forecast HSIC's revenue for 2025 to be $1,578,438,501,925, with the lowest HSIC revenue forecast at $1,569,932,618,331, and the highest HSIC revenue forecast at $1,584,289,438,781. On average, 9 Wall Street analysts forecast HSIC's revenue for 2026 to be $1,633,360,917,190, with the lowest HSIC revenue forecast at $1,624,834,219,554, and the highest HSIC revenue forecast at $1,653,146,185,954.
In 2027, HSIC is forecast to generate $1,690,652,603,419 in revenue, with the lowest revenue forecast at $1,666,097,145,648 and the highest revenue forecast at $1,724,461,667,955.